2023 ESC guidelines: What does it mean to you and your practice in the UK?
Webinar
•
AstraZeneca
About the CPD course
A webinar; led by experts in the field of cardiology across disciplines. Following the publication of the 2023 ESC guidelines (‘Focused update on heart failure’); this webinar allows healthcare professionals to hear from their peers about what the guideline change is and the reasons behind it. As well as outlining the SGLT2i data that has resulted in the update; it details key information regarding clinical implementation; to support healthcare professionals in daily practice to improve patient outcomes.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
